DrugsControl Media Services

News Detail

Quicker decrease in Covid infection treated with Molnupiravir (07-03-2021)

New Delhi, 6 March 2021: Merck and Ridgeback Biotherapeutics, LP on Saturday announced preliminary results from Ridgebacks Phase 2a randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy to eliminate SARS-CoV-2 viral RNA of Molnupira......
View Details

Source : Economic Times

Related News